State of academic knowledge on toxicity and biological fate of quantum dots.
Quantum dots (QDs), an important class of emerging nanomaterial, are widely anticipated to find application in many consumer and clinical products in the near future. Premarket regulatory scrutiny is, thus, an issue gaining considerable attention. Previous review papers have focused primarily on the toxicity of QDs. From the point of view of product regulation, however, parameters that determine exposure (e.g., dosage, transformation, transportation, and persistence) are just as important as inherent toxicity. We have structured our review paper according to regulatory risk assessment practices, in order to improve the utility of existing knowledge in a regulatory context. Herein, we summarize the state of academic knowledge on QDs pertaining not only to toxicity, but also their physicochemical properties, and their biological and environmental fate. We conclude this review with recommendations on how to tailor future research efforts to address the specific needs of regulators.
Pelley
Jennifer L
JL
Regulatory Governance Initiative, School of Public Policy and Administration, Carleton University, Ottawa, Ontario K1S5B6, Canada.
Daar
Abdallah S
AS
Saner
Marc A
MA
D000818:Animals; D006801:Humans; D045663:Quantum Dots; D018570:Risk Assessment; D018675:Toxicity Tests
J Am Chem Soc. 2005 Sep 7;127(35):12196-7
16131177
Science. 2003 May 30;300(5624):1434-6
12775841
J Nanosci Nanotechnol. 2007 Aug;7(8):2567-81
17685272
Nat Med. 2004 Sep;10(9):993-8
15334072
Science. 2002 Nov 29;298(5599):1759-62
12459582
Nat Biotechnol. 2003 Jan;21(1):47-51
12459736
Biol Trace Elem Res. 1996 Dec;55(3):231-9
9096851
J Nucl Med. 2007 Sep;48(9):1511-8
17704240
J Am Chem Soc. 2006 Mar 1;128(8):2526-7
16492023
Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12617-21
12235356
Biochem Biophys Res Commun. 2004 Jan 30;314(1):46-53
14715244
Biomaterials. 2009 Jan;30(1):19-25
18848354
Science. 2005 Jan 28;307(5709):538-44
15681376
Anal Bioanal Chem. 2009 Feb;393(4):1091-105
18836855
Toxicol Appl Pharmacol. 2008 Aug 1;230(3):364-71
18495192
Bioconjug Chem. 2006 Jul-Aug;17(4):920-7
16848398
J Nanosci Nanotechnol. 2007 Feb;7(2):497-503
17450785
Environ Health Perspect. 2007 Sep;115(9):1339-43
17805425
Aquat Toxicol. 2008 Feb 18;86(3):333-40
18160110
Nano Lett. 2006 Apr;6(4):800-8
16608287
J Nanobiotechnology. 2008 Oct 23;6:11
18947410
Rev Environ Health. 2001 Jul-Sep;16(4):233-51
12041880
Nano Lett. 2004 Jan 1;4(1):11-18
28890669
J Mol Med (Berl). 2005 May;83(5):377-85
15688234
Nat Nanotechnol. 2008 Jun;3(6):352-5
18654546
Int J Nanomedicine. 2008;3(2):151-67
18686776
Environ Toxicol Chem. 2008 Sep;27(9):1958-63
19086211
Clin Biochem. 2007 Sep;40(13-14):917-27
17689518
Eur J Pharm Biopharm. 2008 Feb;68(2):153-68
17869074
Anal Chem. 2004 Aug 15;76(16):4806-10
15307792
Toxicol Sci. 2007 Jul;98(1):249-57
17404394
Biochimie. 2006 Nov;88(11):1549-59
17070979
Environ Health Perspect. 2006 Feb;114(2):165-72
16451849
Langmuir. 2007 Feb 13;23(4):1974-80
17279683
BMC Cancer. 2008 Apr 22;8:111
18430208
Toxicol Sci. 2006 May;91(1):159-65
16443688
J Invest Dermatol. 2007 Jan;127(1):143-53
16902417
J Nucl Med. 2007 Nov;48(11):1862-70
17942800
Nucl Med Biol. 2008 May;35(4):501-14
18482688
Environ Health Perspect. 2008 Jul;116(7):915-22
18629314
Bioconjug Chem. 2007 Mar-Apr;18(2):389-96
17263568
Environ Sci Technol. 2008 Aug 15;42(16):6264-70
18767697
Chem Commun (Camb). 2005 Jan 28;(4):528-30
15654392
Biochem Biophys Res Commun. 2003 Mar 14;302(3):496-501
12615061
Bioconjug Chem. 2004 Jan-Feb;15(1):79-86
14733586
Nat Biotechnol. 2007 Oct;25(10):1165-70
17891134
Photochem Photobiol. 2006 May-Jun;82(3):617-25
16475871
Biomaterials. 2007 Nov;28(31):4717-32
17686516
Microbiol Immunol. 2004;48(9):669-75
15383704